Announcements, News & Comments

The Chinese vaccine Sinovac-CoronaVac COVID-19 vaccine has been approved for the World Health Organization’s Emergency Use Listing (EUL). To qualify for the EUL listing, WHO checks the vaccines quality, safety, efficiency as well as...

A new webpage has been added to the USCCC website so that members and clients can give their feedback on our services. Some reviews will be displayed throughout the site. If you would like to add your experience, please visit our 'Endorsements and Reviews' webpage!

The COVID-19 Pandemic has reset the way each of us see life. In many cases, this pandemic has dramatically affected company culture. If you have found that your organization is suffering rather than recovering, U.S.-China Chamber of Commerce would like to recommend a book from our reading list. Bridge the Gap by Michael Rodenberg explores the principles and methodology of strengthening foundations already laid and revitalizing your organization.

Michael is C.E.O. of Murakami Manufacturing USA & Mexico, a Japanese corporation. He has had assignments in Japan, China, and various locations in the United States. Michael is also a long-time friend of the U.S.-China Chamber of Commerce. As such, we have personally observed his experience in cross-cultural relations and leadership. The methods outlined are tried and true, making Bridge the Gap a worthy read full of insight, promise and hope.

Friday, May 14, 2021 - FirstPathway Partners' Chairman and CEO, Bob Kraft, accepts his re-election as Invest in the USA (IIUSA) President for his fifth consecutive year, returning to serve the board for the 2021-2022 term.

The Chinese vaccine Sinopharm from Beijing Institute of Biological Products (known as SARS-CoV-2 Vaccine [Vero Cell]) has been approved for the World Health Organization’s Emergency Use Listing (EUL). | 国药集团北京生物制品研究所新型冠状病毒灭活疫苗（Vero细胞）被接纳世界卫生组织的紧急使用清单。